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Abstract
PURPOSE—To examine choroidal thickness and area in healthy eyes using spectral domain
optical coherence tomography (SD-OCT).
DESIGN—Retrospective, observational case series
METHODS—Thirty-four eyes (34 subjects), with no retinal or choroidal disease, underwent high
definition raster scanning using SD-OCT with frame enhancement software. Choroidal thickness
was measured from the posterior edge of the retinal pigment epithelium to the choroid/sclera
junction at 500 μm intervals up to 2500 μm temporal and nasal to the fovea. The central 1 mm
area of the choroid was also measured, along with foveal thickness of the retina. All measurements
were performed by two independent observers. Statistical analysis was used to correlate inter-
observer findings, choroidal thickness and area measurements with age, and choroidal thickness
with retinal foveal thickness.
RESULTS—The 34 subjects had a mean age of 51.1 years. Reliable measurements of choroidal
thickness were obtainable in 74% of eyes examined. Choroidal thickness and area measurements
had strong inter-observer correlation (r =0.92, P < 0.0001) and (r =0.93, P < 0.0001) respectively.
Area had a moderate negative correlation with age (r =-0.62, P < 0.0001) that was comparable to
the correlation between mean subfoveal choroidal thickness and age (r =-0.61, P < 0.0001).
Retinal and choroidal thickness were found to be poorly correlated (r =-0.23, P = 0.18). Mean
choroidal thickness showed a pattern of thinnest choroid nasally, thickening in the subfoveal
region, and then thinning again temporally. Mean subfoveal choroidal thickness was found to be
272 μm (SD, +/- 81 μm).
CONCLUSIONS—Choroidal thickness can be measured using SD-OCT high definition raster
scans in the majority of eyes. Choroidal thickness across the macula demonstrates a thin choroid
nasally, thickest choroid sub-foveally, and again thinner temporally, and a trend toward decreasing
choroidal thickness with age.
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The introduction of optical coherence tomography1 (OCT) into clinical practice has changed
ophthalmology, and with progression of new technology, the ability to obtain a true, non-
invasive “optical biopsy” of the posterior segment is almost achievable. With advancements
in OCT image processing software, more refined details of the posterior segment can be
appreciated and characterized in vivo. The choroid plays a vital role in the pathophysiology
of many diseases affecting the retina but adequate visualization of the choroid using OCT
has not been possible until recently. Spaide et al recently reported the successful
examination and measurement of choroidal thickness in normal and pathological states using
the Heidelberg Spectralis (Heidelberg Engineering, Heidelberg, Germany) OCT instrument.
2-7 The Spectralis offers eye tracking technology and the capability to capture up to 100 B-
scans in the same position for OCT signal averaging8, 9 and enhancement. Furthermore,
Spaide demonstrated the ability of the spectral domain (SD) OCT systems to show an
inverted OCT image by moving the device close to the patients’ eye. Since spectral domain
detection has highest sensitivity near zero-delay and sensitivity decreases for larger delays,
by doing this, the choroid is closer to the zero-delay line, providing enhanced sensitivity and
increased imaging depth. OCT imaging with longer wavelengths at 1060 nm (compared to
800 nm used in commercial OCT systems) has also been shown to increase signal
penetration into the choroid and optic nerve head.10-15 Ikuno et al have recently
characterized normal choroidal thickness in Japanese subjects using a 1060 nm based light
source.16 The aim of this study was to evaluate another commercially available spectral
domain device, Cirrus-HD OCT (Carl Zeiss Meditec, Inc., Dublin, CA) to see if its new
software, which permits acquisition of 20 B-scans simultaneously in a single raster line scan,
would allow accurate measurement of choroidal thickness and area in normal eyes using
previously proposed measurement techniques.3
The SD Cirrus HD-OCT light source is centered on 800 nm wavelength, achieving 5 μm
axial resolution in tissue. Previously, the full thickness of the choroid could not be seen in
most eyes due to scattering and insufficient light penetration beyond the retinal pigment
epithelium (RPE), as well as, signal strength roll-off distal to the zero-delay line. Selective
pixel profiling™ available in the newest version 4.5 software generates high definition 1 line
raster image from 20 B-scans taken at a single location. This processing software is
comparable to frame averaging, but unique in that images are generated by evaluating all of
the pixel data to reduce noise and construct the best possible image. Decreased signal
strength posterior to the RPE is compensated by this image enhancement software which
enables visualization of the border where choroidal tissue meets sclera and allows choroidal
thickness measurements to be performed.
Methods
A retrospective analysis was performed on 34 eyes of 34 normal patients, who underwent
high definition 1 line raster scanning at the New England Eye Center, Tufts Medical Center,
Boston, MA between November and December 2009. Medical chart review was done to
identify patients with no retinal or choroidal pathology. Patients with a myopic refractive
error of greater than minus 6.0 diopters were excluded from this study. Cirrus HD-OCT
scans were obtained from patients as part of a comprehensive dilated ophthalmological
exam, as well as from undilated healthy volunteers with no visual complaints or history of
ocular pathology.
The 1 line raster is a 6 mm line consisting of 4096 A-scans. The images were taken in the
usual manner and were not inverted to bring the choroid in closer proximity to the zero
delay line, as image inversion using the Cirrus software results in a low resolution, pixilated
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image. To be included in this study, images had to be at least 6 out of 10 in intensity and
taken as close to the fovea as possible, by choosing to image the thinnest point of the
macula, with the understanding that slight differences in positioning could affect the
measured thicknesses. One eye per patient was selected for measurements. If images from
both eyes met inclusion criteria, then the eye in which the choroid/sclera border could be
most clearly visualized was selected. Of the 34 eyes, 13 right eyes and 21 left eyes were
measured in this study. Using the Cirrus linear measurement tool, two independent
observers measured choroidal thickness perpendicularly from the outer edge of the hyper-
reflective RPE to the inner sclera at 500 μm intervals temporal and nasal from the fovea, up
to 2500 μm (Figure 1). Furthermore, the central foveal thickness was also measured at this
time in order to determine the correlation between retinal thickness and choroidal thickness.
Additionally, the area of the choroid in the central 1mm region, 500 μm temporal and nasal
to the fovea was also measured on all images (Figure 1). The 1 line raster images were
exported to publicly available research analysis software, ImageJ (http://rsbweb.nih.gov/ij/).
In order to generate measurements equivalent to Cirrus software, the scale was set by
drawing a line over a line of a known distance, adjusting the pixel aspect ratio to 0.5, and
setting global measurements in microns. The area of interest was then outlined and
calculated in μm2. Two independent observers measured the same area on all normal scans
in order to correlate findings.
A Pearson correlation was applied to choroidal thickness and area with respect to age and
central foveal thickness compared to choroidal thickness. A P value of < 0.01 was
considered statistically significant. All statistics were calculated using SPSS software
(Version 17.0 for Windows, SPSS Inc, Chicago, IL, USA).
Results
Of the 34 subjects, the group consisted of 17 males and 17 females, with an average age of
51.1 years (range, 22 to 78 years). 9 out of 34 were undilated volunteers. All eyes had
normal foveal contour with no retinal pathology and no abnormalities of the choroid. The
delineation between choroid and sclera could be visualized easily to permit reliable
thickness measurements to be performed in 34 out of 46 (74%) of the images evaluated in
this study. Examination of the undilated group separately showed that 9 out of 11 (82%) of
eyes could be measured. Considering the remaining 10 dilated eyes that measurements could
not be obtained in, 6 eyes had 1-2+ nuclear sclerotic cataract (NSC) and 2 had posterior
chamber intraocular lens (PCIOL).
In these 34 eyes, choroidal thickness measurements had strong inter-observer correlation
overall (r = 0.92, P < 0.0001) and at each of the 11 measurement locations (Table 1).
Average thickness of the choroid beneath the fovea was 272 μm (SD, +/- 81 μm).
Mean choroidal thickness at each location was plotted, and the choroid was noted to be
thinnest nasally, thicker in the subfoveal region and then thinner again temporally, however
not as thin as the choroid proximal to the disc (Figure 2). This pattern was in agreement with
previous studies of choroidal thickness in normal eyes.2, 3, 16 The correlation of central
foveal thickness of the retina with choroidal thickness in the area directly beneath the fovea
was also examined. A weak correlation between the two measurements (r = -0.23, P= 0.18)
was found, suggesting that retinal thickness may not be directly related to choroidal
thickness in normal eyes.
The average cross-sectional area of the choroid in the central 1mm region in the 34 eyes was
0.27 mm2. There was strong inter-observer correlation for the area measurements (r = 0.93,
P < 0.0001). There was a moderate negative correlation between age and area (r = -0.62, P <
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0.0001). In this study, the correlation between age and central 1 mm area to be comparable
to the correlation between age and average choroidal thickness beneath the fovea (r = -0.61,
P < 0.0001).
Discussion
The choroid is a highly vascular tissue, necessitating in vivo imaging to accurately determine
its true structure and thickness. Until recently, information regarding choroidal thickness in
normal eyes was based primarily on histological results, which do not necessary reflect the
true measurements of this dynamic tissue. OCT has been well established as an accurate
imaging study of known retinal pathology through good correlation between histology of
animals and humans in vivo17; however exact correlation between OCT and histology is
limited since histological fixation produces artifacts due to processing, tissue deformation,
and shrinkage.18 Recent studies by Spaide et al demonstrated the potential to image
choroidal structure and thickness using new OCT imaging techniques with one
commercially available spectral domain OCT instrument, the Heidelberg Spectralis.
Already, this OCT imaging technique has revealed novel findings of choroidal thickness in
known diseases such as central serous chorioretinopathy5 and myopic degeneration4, and
helped define new entities such as age-related choroidal atrophy.6
Since 2006, a variety of spectral domain OCT instruments have become commercially
available, therefore determining if choroidal thickness measurements were possible using
another one of the commonly used spectral domain OCT devices is of interest. This report
confirms that another simple, reproducible method for choroidal measurement using the
Zeiss Cirrus HD-OCT device is possible in the majority of eyes. Reliable measurements of
choroidal thickness were obtainable in nearly three quarters of examined eyes (74%). The
results of this study were very similar to those reported previously using the Heidelberg
OCT device. The mean subfoveal choroidal thickness was found to be 272 μm (SD, +/- 81
μm), compared to 287 μm (SD, +/- 76 μm) found in the study of normal eyes by Spaide et
al.3 As reported previously3, similar variability of choroidal thickness across the macula in
normal eyes was observed, with the choroid thinnest proximal to the disc. Additionally, a
negative correlation between both area and age and thickness and age was noted, suggesting
that progressive choroidal thinning occurs over time in normal eyes, which is a similar
finding to previous reports. In addition, this study suggests that area measurements might be
another value useful to track changes in choroidal thickness.
The most apparent limitation to this technique is the inability to measure choroidal thickness
in all eyes due to an unclear posterior boundary of the choroid (choroid/sclera junction) in
approximately ¼ of eyes (Figure 3). Reasons for this may be a suboptimal number of
averaged OCT B scans, the lack of eye tracking software, and the potential for eye
movement during imaging with subsequent degradation of the image. Moreover, densely
pigmented RPE and even mild cataracts, which were noted in 60% of dilated eyes that could
not be measured, can attenuate light penetration, particularly at 800 nm wavelength, which
further contributes to obscuration of the choroid/sclera boundary. The frequency at which
normal choroidal thickness can be measured in this study and the previously mentioned
study of normal choroidal thickness3 cannot be compared as data regarding the percentage
of eyes meeting inclusion criteria which could not be successfully measured was not
reported.
In the future, segmentation software that could define choroidal thickness and volume might
prove to be a valuable measure in tracking choroidal changes. Currently, both Cirrus and
Heidelberg OCT devices are limited by the number of lines that can be scanned at one time
due to the large numbers of scans that need to be processed or averaged. Therefore, two
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dimensional mapping of the choroid thickness across the fundus becomes difficult due to the
large number of scans that are required, as well, as lengthy measurement times. Potential
new software may also improve image inversion, image averaging, and signal-to-noise ratio,
thus further improving visualization of choroidal structures. Studies have demonstrated that
imaging at 1050 nm wavelength provides superior choroidal penetration13-15; however, the
present software enhanced the capabilities of an 800 nm based system to provide good
visualization of the choroid.
In summary, choroidal thickness can be measured using Cirrus HD-OCT high definition
raster scans in the majority of eyes. Our findings were similar to those previously described
using the Heidelberg Spectralis device, including a thinner choroid nasally, thickest choroid
sub-foveally, and again thinner temporally, and a trend toward decreasing choroidal
thickness with age. Improved in vivo visualization of the choroid and measurement of
choroidal thickness using OCT is likely to improve our understanding of a variety of
ophthalmic diseases in the future.
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FIGURE 1. Choroidal thickness measurements on Cirrus HD-OCT high definition 1 line raster
scans
(Top) Demonstration of normal choroidal thickness measured at 500 μm intervals, up to
2500 μm temporal and nasal to the fovea. Perpendicular lines were drawn from posterior
edge of the retinal pigment epithelium to the choroid/sclera junction using Cirrus HD-OCT
software. (Bottom) Central 1 mm cross-sectional area of choroid measured using ImageJ
analysis software; outlined area is 0.32 mm2.
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FIGURE 2. Graph of mean macular choroidal thickness in normal eyes
Mean thickness at each of the 11 locations measured at 500 μm (0.5 mm) intervals temporal
(T) and nasal (N) to the fovea (F).
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FIGURE 3. Cirrus HD-OCT 1 line raster scans demonstrating poor visualization of posterior
choroid/sclera junction
Example OCT images from two different subjects with (Top) 2+ NSC and (Bottom) a
PCIOL respectively in which full choroidal thickness could not be assessed and
measurements could not be performed.
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TABLE 1
Mean Choroidal Thickness and Inter-observer Correlation of Measurements
Location (mm from fovea) Mean Choroidal Thickness (μm) Inter-observer Correlation (r) P value
Temporal 2.5 218 0.88 < 0.0001
Temporal 2.0 237 0.89 < 0.0001
Temporal 1.5 248 0.90 < 0.0001
Temporal 1.0 256 0.88 < 0.0001
Temporal 0.5 264 0.94 < 0.0001
Fovea 272 0.92 < 0.0001
Nasal 0.5 261 0.92 < 0.0001
Nasal 1.0 248 0.90 < 0.0001
Nasal 1.5 217 0.91 < 0.0001
Nasal 2.0 186 0.95 < 0.0001
Nasal 2.5 157 0.94 < 0.0001
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